nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—ABCB1—Mitomycin—urinary bladder cancer	0.157	0.275	CbGbCtD
Candesartan—PTGS1—Etoposide—urinary bladder cancer	0.0824	0.144	CbGbCtD
Candesartan—CYP2C8—Fluorouracil—urinary bladder cancer	0.057	0.0999	CbGbCtD
Candesartan—CYP2C8—Etoposide—urinary bladder cancer	0.0475	0.0834	CbGbCtD
Candesartan—ABCB1—Gemcitabine—urinary bladder cancer	0.0451	0.079	CbGbCtD
Candesartan—CYP2C9—Fluorouracil—urinary bladder cancer	0.0397	0.0697	CbGbCtD
Candesartan—CYP2C9—Cisplatin—urinary bladder cancer	0.0338	0.0592	CbGbCtD
Candesartan—ABCB1—Cisplatin—urinary bladder cancer	0.0328	0.0574	CbGbCtD
Candesartan—ABCB1—Etoposide—urinary bladder cancer	0.0322	0.0564	CbGbCtD
Candesartan—ABCB1—Doxorubicin—urinary bladder cancer	0.022	0.0385	CbGbCtD
Candesartan—ABCB1—Methotrexate—urinary bladder cancer	0.0213	0.0373	CbGbCtD
Candesartan—CYP2C9—urine—urinary bladder cancer	0.00426	0.125	CbGeAlD
Candesartan—AGTR1—prostate gland—urinary bladder cancer	0.00317	0.0931	CbGeAlD
Candesartan—Losartan—UGT2B7—urinary bladder cancer	0.00296	0.381	CrCbGaD
Candesartan—Pranlukast—TNF—urinary bladder cancer	0.00258	0.332	CrCbGaD
Candesartan—AGTR1—epithelium—urinary bladder cancer	0.00233	0.0684	CbGeAlD
Candesartan—AGTR1—smooth muscle tissue—urinary bladder cancer	0.00225	0.0659	CbGeAlD
Candesartan—Telmisartan—PPARG—urinary bladder cancer	0.00223	0.287	CrCbGaD
Candesartan—AGTR1—renal system—urinary bladder cancer	0.00216	0.0635	CbGeAlD
Candesartan—AGTR1—female reproductive system—urinary bladder cancer	0.00173	0.0508	CbGeAlD
Candesartan—AGTR1—vagina—urinary bladder cancer	0.00157	0.046	CbGeAlD
Candesartan—PTGS1—prostate gland—urinary bladder cancer	0.0014	0.0409	CbGeAlD
Candesartan—PTGS1—seminal vesicle—urinary bladder cancer	0.00118	0.0346	CbGeAlD
Candesartan—CYP2C8—renal system—urinary bladder cancer	0.00117	0.0344	CbGeAlD
Candesartan—PTGS1—epithelium—urinary bladder cancer	0.00103	0.0301	CbGeAlD
Candesartan—AGTR1—lymph node—urinary bladder cancer	0.00101	0.0297	CbGeAlD
Candesartan—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000988	0.029	CbGeAlD
Candesartan—PTGS1—renal system—urinary bladder cancer	0.000951	0.0279	CbGeAlD
Candesartan—CYP2C8—female reproductive system—urinary bladder cancer	0.000939	0.0276	CbGeAlD
Candesartan—CYP2C8—vagina—urinary bladder cancer	0.00085	0.0249	CbGeAlD
Candesartan—CYP2C9—female reproductive system—urinary bladder cancer	0.000834	0.0245	CbGeAlD
Candesartan—ABCB1—prostate gland—urinary bladder cancer	0.000825	0.0242	CbGeAlD
Candesartan—PTGS1—female reproductive system—urinary bladder cancer	0.000762	0.0224	CbGeAlD
Candesartan—ABCB1—seminal vesicle—urinary bladder cancer	0.000698	0.0205	CbGeAlD
Candesartan—PTGS1—vagina—urinary bladder cancer	0.000689	0.0202	CbGeAlD
Candesartan—ABCB1—epithelium—urinary bladder cancer	0.000606	0.0178	CbGeAlD
Candesartan—ABCB1—renal system—urinary bladder cancer	0.000562	0.0165	CbGeAlD
Candesartan—ABCB1—urethra—urinary bladder cancer	0.000552	0.0162	CbGeAlD
Candesartan—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000468	0.00186	CcSEcCtD
Candesartan—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000466	0.00185	CcSEcCtD
Candesartan—Tachycardia—Fluorouracil—urinary bladder cancer	0.000464	0.00185	CcSEcCtD
Candesartan—Renal impairment—Doxorubicin—urinary bladder cancer	0.000458	0.00182	CcSEcCtD
Candesartan—Urticaria—Thiotepa—urinary bladder cancer	0.000457	0.00182	CcSEcCtD
Candesartan—Vertigo—Etoposide—urinary bladder cancer	0.000455	0.00181	CcSEcCtD
Candesartan—Abdominal pain—Thiotepa—urinary bladder cancer	0.000455	0.00181	CcSEcCtD
Candesartan—Body temperature increased—Thiotepa—urinary bladder cancer	0.000455	0.00181	CcSEcCtD
Candesartan—Leukopenia—Etoposide—urinary bladder cancer	0.000453	0.0018	CcSEcCtD
Candesartan—Hypotension—Gemcitabine—urinary bladder cancer	0.000452	0.0018	CcSEcCtD
Candesartan—ABCB1—female reproductive system—urinary bladder cancer	0.00045	0.0132	CbGeAlD
Candesartan—Cardiac failure—Doxorubicin—urinary bladder cancer	0.000447	0.00178	CcSEcCtD
Candesartan—PTGS1—lymph node—urinary bladder cancer	0.000446	0.0131	CbGeAlD
Candesartan—Hypotension—Fluorouracil—urinary bladder cancer	0.000445	0.00177	CcSEcCtD
Candesartan—Cough—Etoposide—urinary bladder cancer	0.000442	0.00176	CcSEcCtD
Candesartan—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000442	0.00176	CcSEcCtD
Candesartan—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.000442	0.00176	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000441	0.00176	CcSEcCtD
Candesartan—Tachycardia—Cisplatin—urinary bladder cancer	0.00044	0.00175	CcSEcCtD
Candesartan—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.000438	0.00174	CcSEcCtD
Candesartan—Hypertension—Etoposide—urinary bladder cancer	0.000437	0.00174	CcSEcCtD
Candesartan—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000436	0.00174	CcSEcCtD
Candesartan—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000435	0.00173	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000433	0.00173	CcSEcCtD
Candesartan—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000431	0.00172	CcSEcCtD
Candesartan—Chest pain—Etoposide—urinary bladder cancer	0.000431	0.00172	CcSEcCtD
Candesartan—Somnolence—Gemcitabine—urinary bladder cancer	0.00043	0.00171	CcSEcCtD
Candesartan—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000427	0.0017	CcSEcCtD
Candesartan—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000424	0.00169	CcSEcCtD
Candesartan—Somnolence—Fluorouracil—urinary bladder cancer	0.000423	0.00168	CcSEcCtD
Candesartan—Hypotension—Cisplatin—urinary bladder cancer	0.000421	0.00168	CcSEcCtD
Candesartan—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000419	0.00167	CcSEcCtD
Candesartan—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000418	0.00166	CcSEcCtD
Candesartan—Fatigue—Gemcitabine—urinary bladder cancer	0.000417	0.00166	CcSEcCtD
Candesartan—Asthenia—Thiotepa—urinary bladder cancer	0.000413	0.00164	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000411	0.00164	CcSEcCtD
Candesartan—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000411	0.00164	CcSEcCtD
Candesartan—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.000409	0.00163	CcSEcCtD
Candesartan—ABCB1—vagina—urinary bladder cancer	0.000407	0.012	CbGeAlD
Candesartan—Neutropenia—Methotrexate—urinary bladder cancer	0.000407	0.00162	CcSEcCtD
Candesartan—Pruritus—Thiotepa—urinary bladder cancer	0.000407	0.00162	CcSEcCtD
Candesartan—Paraesthesia—Cisplatin—urinary bladder cancer	0.000405	0.00161	CcSEcCtD
Candesartan—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000405	0.00161	CcSEcCtD
Candesartan—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	0.000405	0.00161	CcSEcCtD
Candesartan—Tachycardia—Etoposide—urinary bladder cancer	0.000403	0.00161	CcSEcCtD
Candesartan—Dyspnoea—Cisplatin—urinary bladder cancer	0.000402	0.0016	CcSEcCtD
Candesartan—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000399	0.00159	CcSEcCtD
Candesartan—Angina pectoris—Epirubicin—urinary bladder cancer	0.000397	0.00158	CcSEcCtD
Candesartan—Diarrhoea—Thiotepa—urinary bladder cancer	0.000394	0.00157	CcSEcCtD
Candesartan—Bronchitis—Epirubicin—urinary bladder cancer	0.000392	0.00156	CcSEcCtD
Candesartan—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000389	0.00155	CcSEcCtD
Candesartan—Hypotension—Etoposide—urinary bladder cancer	0.000386	0.00154	CcSEcCtD
Candesartan—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000383	0.00152	CcSEcCtD
Candesartan—Renal failure—Methotrexate—urinary bladder cancer	0.000381	0.00152	CcSEcCtD
Candesartan—Neutropenia—Epirubicin—urinary bladder cancer	0.000381	0.00152	CcSEcCtD
Candesartan—Dizziness—Thiotepa—urinary bladder cancer	0.00038	0.00151	CcSEcCtD
Candesartan—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	0.000379	0.00151	CcSEcCtD
Candesartan—Urticaria—Fluorouracil—urinary bladder cancer	0.000378	0.0015	CcSEcCtD
Candesartan—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000376	0.0015	CcSEcCtD
Candesartan—Paraesthesia—Etoposide—urinary bladder cancer	0.000371	0.00148	CcSEcCtD
Candesartan—Haematuria—Methotrexate—urinary bladder cancer	0.00037	0.00147	CcSEcCtD
Candesartan—Dyspnoea—Etoposide—urinary bladder cancer	0.000368	0.00147	CcSEcCtD
Candesartan—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000367	0.00146	CcSEcCtD
Candesartan—Somnolence—Etoposide—urinary bladder cancer	0.000367	0.00146	CcSEcCtD
Candesartan—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000367	0.00146	CcSEcCtD
Candesartan—Epistaxis—Methotrexate—urinary bladder cancer	0.000366	0.00146	CcSEcCtD
Candesartan—Vomiting—Thiotepa—urinary bladder cancer	0.000366	0.00146	CcSEcCtD
Candesartan—Rash—Thiotepa—urinary bladder cancer	0.000363	0.00144	CcSEcCtD
Candesartan—Bronchitis—Doxorubicin—urinary bladder cancer	0.000362	0.00144	CcSEcCtD
Candesartan—Dermatitis—Thiotepa—urinary bladder cancer	0.000362	0.00144	CcSEcCtD
Candesartan—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000362	0.00144	CcSEcCtD
Candesartan—Headache—Thiotepa—urinary bladder cancer	0.00036	0.00143	CcSEcCtD
Candesartan—Renal failure—Epirubicin—urinary bladder cancer	0.000357	0.00142	CcSEcCtD
Candesartan—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000357	0.00142	CcSEcCtD
Candesartan—Body temperature increased—Cisplatin—urinary bladder cancer	0.000357	0.00142	CcSEcCtD
Candesartan—Fatigue—Etoposide—urinary bladder cancer	0.000356	0.00142	CcSEcCtD
Candesartan—Neutropenia—Doxorubicin—urinary bladder cancer	0.000352	0.0014	CcSEcCtD
Candesartan—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.00035	0.00139	CcSEcCtD
Candesartan—Haemoglobin—Methotrexate—urinary bladder cancer	0.00035	0.00139	CcSEcCtD
Candesartan—Haemorrhage—Methotrexate—urinary bladder cancer	0.000348	0.00139	CcSEcCtD
Candesartan—Hepatitis—Methotrexate—urinary bladder cancer	0.000348	0.00139	CcSEcCtD
Candesartan—Asthenia—Gemcitabine—urinary bladder cancer	0.000347	0.00138	CcSEcCtD
Candesartan—Haematuria—Epirubicin—urinary bladder cancer	0.000346	0.00138	CcSEcCtD
Candesartan—Pharyngitis—Methotrexate—urinary bladder cancer	0.000346	0.00138	CcSEcCtD
Candesartan—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000344	0.00137	CcSEcCtD
Candesartan—Epistaxis—Epirubicin—urinary bladder cancer	0.000343	0.00136	CcSEcCtD
Candesartan—Pruritus—Gemcitabine—urinary bladder cancer	0.000342	0.00136	CcSEcCtD
Candesartan—Nausea—Thiotepa—urinary bladder cancer	0.000342	0.00136	CcSEcCtD
Candesartan—Urethral disorder—Methotrexate—urinary bladder cancer	0.000342	0.00136	CcSEcCtD
Candesartan—Sinusitis—Epirubicin—urinary bladder cancer	0.000341	0.00136	CcSEcCtD
Candesartan—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.00034	0.00135	CcSEcCtD
Candesartan—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000339	0.00135	CcSEcCtD
Candesartan—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000338	0.00135	CcSEcCtD
Candesartan—Pruritus—Fluorouracil—urinary bladder cancer	0.000337	0.00134	CcSEcCtD
Candesartan—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000331	0.00132	CcSEcCtD
Candesartan—Renal failure—Doxorubicin—urinary bladder cancer	0.00033	0.00132	CcSEcCtD
Candesartan—Urticaria—Etoposide—urinary bladder cancer	0.000328	0.00131	CcSEcCtD
Candesartan—Haemoglobin—Epirubicin—urinary bladder cancer	0.000328	0.0013	CcSEcCtD
Candesartan—Rhinitis—Epirubicin—urinary bladder cancer	0.000327	0.0013	CcSEcCtD
Candesartan—Body temperature increased—Etoposide—urinary bladder cancer	0.000327	0.0013	CcSEcCtD
Candesartan—Abdominal pain—Etoposide—urinary bladder cancer	0.000327	0.0013	CcSEcCtD
Candesartan—Haemorrhage—Epirubicin—urinary bladder cancer	0.000326	0.0013	CcSEcCtD
Candesartan—Hepatitis—Epirubicin—urinary bladder cancer	0.000326	0.0013	CcSEcCtD
Candesartan—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000326	0.0013	CcSEcCtD
Candesartan—Asthenia—Cisplatin—urinary bladder cancer	0.000324	0.00129	CcSEcCtD
Candesartan—Pharyngitis—Epirubicin—urinary bladder cancer	0.000324	0.00129	CcSEcCtD
Candesartan—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000322	0.00128	CcSEcCtD
Candesartan—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000321	0.00128	CcSEcCtD
Candesartan—Haematuria—Doxorubicin—urinary bladder cancer	0.00032	0.00128	CcSEcCtD
Candesartan—Urethral disorder—Epirubicin—urinary bladder cancer	0.00032	0.00127	CcSEcCtD
Candesartan—Epistaxis—Doxorubicin—urinary bladder cancer	0.000317	0.00126	CcSEcCtD
Candesartan—Sinusitis—Doxorubicin—urinary bladder cancer	0.000315	0.00126	CcSEcCtD
Candesartan—Dizziness—Fluorouracil—urinary bladder cancer	0.000315	0.00125	CcSEcCtD
Candesartan—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000314	0.00125	CcSEcCtD
Candesartan—Diarrhoea—Cisplatin—urinary bladder cancer	0.000309	0.00123	CcSEcCtD
Candesartan—Vomiting—Gemcitabine—urinary bladder cancer	0.000308	0.00122	CcSEcCtD
Candesartan—Mental disorder—Methotrexate—urinary bladder cancer	0.000305	0.00122	CcSEcCtD
Candesartan—Rash—Gemcitabine—urinary bladder cancer	0.000305	0.00121	CcSEcCtD
Candesartan—Dermatitis—Gemcitabine—urinary bladder cancer	0.000305	0.00121	CcSEcCtD
Candesartan—Malnutrition—Methotrexate—urinary bladder cancer	0.000303	0.00121	CcSEcCtD
Candesartan—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000303	0.00121	CcSEcCtD
Candesartan—Headache—Gemcitabine—urinary bladder cancer	0.000303	0.00121	CcSEcCtD
Candesartan—Vomiting—Fluorouracil—urinary bladder cancer	0.000303	0.0012	CcSEcCtD
Candesartan—Rhinitis—Doxorubicin—urinary bladder cancer	0.000302	0.0012	CcSEcCtD
Candesartan—Hepatitis—Doxorubicin—urinary bladder cancer	0.000302	0.0012	CcSEcCtD
Candesartan—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000302	0.0012	CcSEcCtD
Candesartan—Rash—Fluorouracil—urinary bladder cancer	0.0003	0.00119	CcSEcCtD
Candesartan—Dermatitis—Fluorouracil—urinary bladder cancer	0.0003	0.00119	CcSEcCtD
Candesartan—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000299	0.00119	CcSEcCtD
Candesartan—Headache—Fluorouracil—urinary bladder cancer	0.000298	0.00119	CcSEcCtD
Candesartan—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000298	0.00119	CcSEcCtD
Candesartan—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000297	0.00118	CcSEcCtD
Candesartan—Asthenia—Etoposide—urinary bladder cancer	0.000296	0.00118	CcSEcCtD
Candesartan—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000296	0.00118	CcSEcCtD
Candesartan—Back pain—Methotrexate—urinary bladder cancer	0.000293	0.00117	CcSEcCtD
Candesartan—Pruritus—Etoposide—urinary bladder cancer	0.000292	0.00116	CcSEcCtD
Candesartan—Nausea—Gemcitabine—urinary bladder cancer	0.000287	0.00114	CcSEcCtD
Candesartan—Vomiting—Cisplatin—urinary bladder cancer	0.000287	0.00114	CcSEcCtD
Candesartan—Mental disorder—Epirubicin—urinary bladder cancer	0.000286	0.00114	CcSEcCtD
Candesartan—Rash—Cisplatin—urinary bladder cancer	0.000284	0.00113	CcSEcCtD
Candesartan—Dermatitis—Cisplatin—urinary bladder cancer	0.000284	0.00113	CcSEcCtD
Candesartan—Malnutrition—Epirubicin—urinary bladder cancer	0.000284	0.00113	CcSEcCtD
Candesartan—Diarrhoea—Etoposide—urinary bladder cancer	0.000283	0.00113	CcSEcCtD
Candesartan—Nausea—Fluorouracil—urinary bladder cancer	0.000283	0.00113	CcSEcCtD
Candesartan—Anaemia—Methotrexate—urinary bladder cancer	0.00028	0.00112	CcSEcCtD
Candesartan—Back pain—Epirubicin—urinary bladder cancer	0.000275	0.00109	CcSEcCtD
Candesartan—Dizziness—Etoposide—urinary bladder cancer	0.000273	0.00109	CcSEcCtD
Candesartan—Vertigo—Methotrexate—urinary bladder cancer	0.000272	0.00108	CcSEcCtD
Candesartan—Leukopenia—Methotrexate—urinary bladder cancer	0.000271	0.00108	CcSEcCtD
Candesartan—Nausea—Cisplatin—urinary bladder cancer	0.000268	0.00107	CcSEcCtD
Candesartan—Cough—Methotrexate—urinary bladder cancer	0.000265	0.00105	CcSEcCtD
Candesartan—Mental disorder—Doxorubicin—urinary bladder cancer	0.000264	0.00105	CcSEcCtD
Candesartan—ABCB1—lymph node—urinary bladder cancer	0.000263	0.00773	CbGeAlD
Candesartan—Vomiting—Etoposide—urinary bladder cancer	0.000263	0.00105	CcSEcCtD
Candesartan—Malnutrition—Doxorubicin—urinary bladder cancer	0.000263	0.00105	CcSEcCtD
Candesartan—Anaemia—Epirubicin—urinary bladder cancer	0.000262	0.00104	CcSEcCtD
Candesartan—Rash—Etoposide—urinary bladder cancer	0.000261	0.00104	CcSEcCtD
Candesartan—Dermatitis—Etoposide—urinary bladder cancer	0.00026	0.00104	CcSEcCtD
Candesartan—Headache—Etoposide—urinary bladder cancer	0.000259	0.00103	CcSEcCtD
Candesartan—Arthralgia—Methotrexate—urinary bladder cancer	0.000258	0.00103	CcSEcCtD
Candesartan—Myalgia—Methotrexate—urinary bladder cancer	0.000258	0.00103	CcSEcCtD
Candesartan—Chest pain—Methotrexate—urinary bladder cancer	0.000258	0.00103	CcSEcCtD
Candesartan—Vertigo—Epirubicin—urinary bladder cancer	0.000255	0.00102	CcSEcCtD
Candesartan—Leukopenia—Epirubicin—urinary bladder cancer	0.000254	0.00101	CcSEcCtD
Candesartan—Back pain—Doxorubicin—urinary bladder cancer	0.000254	0.00101	CcSEcCtD
Candesartan—Palpitations—Epirubicin—urinary bladder cancer	0.000251	0.000999	CcSEcCtD
Candesartan—Cough—Epirubicin—urinary bladder cancer	0.000248	0.000986	CcSEcCtD
Candesartan—Nausea—Etoposide—urinary bladder cancer	0.000245	0.000977	CcSEcCtD
Candesartan—Hypertension—Epirubicin—urinary bladder cancer	0.000245	0.000976	CcSEcCtD
Candesartan—Anaemia—Doxorubicin—urinary bladder cancer	0.000243	0.000966	CcSEcCtD
Candesartan—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000242	0.000965	CcSEcCtD
Candesartan—Chest pain—Epirubicin—urinary bladder cancer	0.000242	0.000962	CcSEcCtD
Candesartan—Arthralgia—Epirubicin—urinary bladder cancer	0.000242	0.000962	CcSEcCtD
Candesartan—Myalgia—Epirubicin—urinary bladder cancer	0.000242	0.000962	CcSEcCtD
Candesartan—Anxiety—Epirubicin—urinary bladder cancer	0.000241	0.000959	CcSEcCtD
Candesartan—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000239	0.000953	CcSEcCtD
Candesartan—Vertigo—Doxorubicin—urinary bladder cancer	0.000236	0.000939	CcSEcCtD
Candesartan—Leukopenia—Doxorubicin—urinary bladder cancer	0.000235	0.000936	CcSEcCtD
Candesartan—Palpitations—Doxorubicin—urinary bladder cancer	0.000232	0.000924	CcSEcCtD
Candesartan—Hypotension—Methotrexate—urinary bladder cancer	0.000231	0.000921	CcSEcCtD
Candesartan—Cough—Doxorubicin—urinary bladder cancer	0.000229	0.000912	CcSEcCtD
Candesartan—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000227	0.000903	CcSEcCtD
Candesartan—Hypertension—Doxorubicin—urinary bladder cancer	0.000227	0.000903	CcSEcCtD
Candesartan—Tachycardia—Epirubicin—urinary bladder cancer	0.000226	0.0009	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000226	0.000898	CcSEcCtD
Candesartan—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000224	0.000891	CcSEcCtD
Candesartan—Arthralgia—Doxorubicin—urinary bladder cancer	0.000224	0.00089	CcSEcCtD
Candesartan—Chest pain—Doxorubicin—urinary bladder cancer	0.000224	0.00089	CcSEcCtD
Candesartan—Myalgia—Doxorubicin—urinary bladder cancer	0.000224	0.00089	CcSEcCtD
Candesartan—Anxiety—Doxorubicin—urinary bladder cancer	0.000223	0.000887	CcSEcCtD
Candesartan—Paraesthesia—Methotrexate—urinary bladder cancer	0.000222	0.000885	CcSEcCtD
Candesartan—Dyspnoea—Methotrexate—urinary bladder cancer	0.000221	0.000879	CcSEcCtD
Candesartan—Somnolence—Methotrexate—urinary bladder cancer	0.00022	0.000876	CcSEcCtD
Candesartan—Dyspepsia—Methotrexate—urinary bladder cancer	0.000218	0.000867	CcSEcCtD
Candesartan—Hypotension—Epirubicin—urinary bladder cancer	0.000216	0.000862	CcSEcCtD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000214	0.00157	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000214	0.000851	CcSEcCtD
Candesartan—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000214	0.00156	CbGpPWpGaD
Candesartan—Fatigue—Methotrexate—urinary bladder cancer	0.000213	0.00085	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000211	0.00084	CcSEcCtD
Candesartan—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000211	0.00154	CbGpPWpGaD
Candesartan—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00021	0.000835	CcSEcCtD
Candesartan—CYP2C8—Biological oxidations—HPGDS—urinary bladder cancer	0.00021	0.00153	CbGpPWpGaD
Candesartan—Tachycardia—Doxorubicin—urinary bladder cancer	0.000209	0.000833	CcSEcCtD
Candesartan—Paraesthesia—Epirubicin—urinary bladder cancer	0.000208	0.000828	CcSEcCtD
Candesartan—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000207	0.000825	CcSEcCtD
Candesartan—Dyspnoea—Epirubicin—urinary bladder cancer	0.000207	0.000822	CcSEcCtD
Candesartan—Somnolence—Epirubicin—urinary bladder cancer	0.000206	0.00082	CcSEcCtD
Candesartan—UGT1A3—Metabolism—UGT2B7—urinary bladder cancer	0.000206	0.00151	CbGpPWpGaD
Candesartan—Dyspepsia—Epirubicin—urinary bladder cancer	0.000204	0.000812	CcSEcCtD
Candesartan—CYP2C8—Biological oxidations—GSTT1—urinary bladder cancer	0.000203	0.00149	CbGpPWpGaD
Candesartan—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000202	0.000806	CcSEcCtD
Candesartan—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	0.000201	0.00147	CbGpPWpGaD
Candesartan—Hypotension—Doxorubicin—urinary bladder cancer	0.0002	0.000797	CcSEcCtD
Candesartan—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.0002	0.000796	CcSEcCtD
Candesartan—Fatigue—Epirubicin—urinary bladder cancer	0.0002	0.000795	CcSEcCtD
Candesartan—Urticaria—Methotrexate—urinary bladder cancer	0.000197	0.000783	CcSEcCtD
Candesartan—CYP2C8—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000196	0.00144	CbGpPWpGaD
Candesartan—Abdominal pain—Methotrexate—urinary bladder cancer	0.000196	0.000779	CcSEcCtD
Candesartan—Body temperature increased—Methotrexate—urinary bladder cancer	0.000196	0.000779	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000195	0.000777	CcSEcCtD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—urinary bladder cancer	0.000194	0.00142	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000193	0.00141	CbGpPWpGaD
Candesartan—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000192	0.000766	CcSEcCtD
Candesartan—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000191	0.000761	CcSEcCtD
Candesartan—Somnolence—Doxorubicin—urinary bladder cancer	0.000191	0.000759	CcSEcCtD
Candesartan—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000189	0.000754	CcSEcCtD
Candesartan—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000189	0.000751	CcSEcCtD
Candesartan—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000189	0.00138	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP4B1—urinary bladder cancer	0.000185	0.00136	CbGpPWpGaD
Candesartan—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000185	0.000737	CcSEcCtD
Candesartan—Fatigue—Doxorubicin—urinary bladder cancer	0.000185	0.000736	CcSEcCtD
Candesartan—Urticaria—Epirubicin—urinary bladder cancer	0.000184	0.000733	CcSEcCtD
Candesartan—Body temperature increased—Epirubicin—urinary bladder cancer	0.000183	0.000729	CcSEcCtD
Candesartan—Abdominal pain—Epirubicin—urinary bladder cancer	0.000183	0.000729	CcSEcCtD
Candesartan—Asthenia—Methotrexate—urinary bladder cancer	0.000178	0.000707	CcSEcCtD
Candesartan—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000175	0.000698	CcSEcCtD
Candesartan—Pruritus—Methotrexate—urinary bladder cancer	0.000175	0.000697	CcSEcCtD
Candesartan—UGT1A3—Metabolism—SLC19A1—urinary bladder cancer	0.000175	0.00128	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.000171	0.00125	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PRSS3—urinary bladder cancer	0.000171	0.00125	CbGpPWpGaD
Candesartan—Urticaria—Doxorubicin—urinary bladder cancer	0.00017	0.000678	CcSEcCtD
Candesartan—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000169	0.000675	CcSEcCtD
Candesartan—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000169	0.000675	CcSEcCtD
Candesartan—Diarrhoea—Methotrexate—urinary bladder cancer	0.000169	0.000674	CcSEcCtD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000168	0.00123	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000167	0.00122	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000167	0.00122	CbGpPWpGaD
Candesartan—Asthenia—Epirubicin—urinary bladder cancer	0.000166	0.000662	CcSEcCtD
Candesartan—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000166	0.00121	CbGpPWpGaD
Candesartan—Pruritus—Epirubicin—urinary bladder cancer	0.000164	0.000652	CcSEcCtD
Candesartan—Dizziness—Methotrexate—urinary bladder cancer	0.000164	0.000652	CcSEcCtD
Candesartan—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.00016	0.00117	CbGpPWpGaD
Candesartan—Diarrhoea—Epirubicin—urinary bladder cancer	0.000158	0.000631	CcSEcCtD
Candesartan—Vomiting—Methotrexate—urinary bladder cancer	0.000157	0.000627	CcSEcCtD
Candesartan—Rash—Methotrexate—urinary bladder cancer	0.000156	0.000621	CcSEcCtD
Candesartan—Dermatitis—Methotrexate—urinary bladder cancer	0.000156	0.000621	CcSEcCtD
Candesartan—Headache—Methotrexate—urinary bladder cancer	0.000155	0.000617	CcSEcCtD
Candesartan—Asthenia—Doxorubicin—urinary bladder cancer	0.000154	0.000612	CcSEcCtD
Candesartan—Dizziness—Epirubicin—urinary bladder cancer	0.000153	0.00061	CcSEcCtD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000152	0.00111	CbGpPWpGaD
Candesartan—Pruritus—Doxorubicin—urinary bladder cancer	0.000152	0.000604	CcSEcCtD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000151	0.00111	CbGpPWpGaD
Candesartan—Vomiting—Epirubicin—urinary bladder cancer	0.000147	0.000586	CcSEcCtD
Candesartan—Nausea—Methotrexate—urinary bladder cancer	0.000147	0.000585	CcSEcCtD
Candesartan—AGTR1—Signaling Pathways—HDAC4—urinary bladder cancer	0.000147	0.00107	CbGpPWpGaD
Candesartan—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000147	0.000584	CcSEcCtD
Candesartan—Rash—Epirubicin—urinary bladder cancer	0.000146	0.000581	CcSEcCtD
Candesartan—Dermatitis—Epirubicin—urinary bladder cancer	0.000146	0.000581	CcSEcCtD
Candesartan—Headache—Epirubicin—urinary bladder cancer	0.000145	0.000578	CcSEcCtD
Candesartan—Dizziness—Doxorubicin—urinary bladder cancer	0.000142	0.000564	CcSEcCtD
Candesartan—CYP2C8—Biological oxidations—GSTP1—urinary bladder cancer	0.000141	0.00103	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000139	0.00102	CbGpPWpGaD
Candesartan—Nausea—Epirubicin—urinary bladder cancer	0.000138	0.000548	CcSEcCtD
Candesartan—UGT1A3—Metabolism—TYMP—urinary bladder cancer	0.000136	0.000998	CbGpPWpGaD
Candesartan—Vomiting—Doxorubicin—urinary bladder cancer	0.000136	0.000543	CcSEcCtD
Candesartan—Rash—Doxorubicin—urinary bladder cancer	0.000135	0.000538	CcSEcCtD
Candesartan—Dermatitis—Doxorubicin—urinary bladder cancer	0.000135	0.000538	CcSEcCtD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000134	0.000984	CbGpPWpGaD
Candesartan—Headache—Doxorubicin—urinary bladder cancer	0.000134	0.000535	CcSEcCtD
Candesartan—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	0.000134	0.000978	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	0.00013	0.000955	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.00013	0.000953	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—GSTM1—urinary bladder cancer	0.00013	0.000948	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	0.000129	0.000941	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000128	0.000935	CbGpPWpGaD
Candesartan—Nausea—Doxorubicin—urinary bladder cancer	0.000127	0.000507	CcSEcCtD
Candesartan—PTGS1—Metabolism—GSTO2—urinary bladder cancer	0.000127	0.000927	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NAT1—urinary bladder cancer	0.000127	0.000927	CbGpPWpGaD
Candesartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	0.000126	0.000921	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000125	0.000912	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NAT2—urinary bladder cancer	0.000123	0.000902	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000123	0.000902	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—GLI1—urinary bladder cancer	0.000123	0.000901	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	0.000121	0.000889	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	0.000116	0.000848	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	0.000115	0.000841	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000115	0.00084	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.000114	0.000833	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000113	0.000828	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00011	0.000806	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	0.00011	0.000804	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.000107	0.000782	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—RRM2—urinary bladder cancer	0.000106	0.000779	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.000105	0.000771	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000105	0.000768	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	0.000104	0.000764	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000104	0.000761	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	0.000103	0.000755	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCL8—urinary bladder cancer	9.92e-05	0.000726	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—HPGDS—urinary bladder cancer	9.86e-05	0.000721	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ENO2—urinary bladder cancer	9.86e-05	0.000721	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	9.86e-05	0.000721	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PRSS3—urinary bladder cancer	9.61e-05	0.000703	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTT1—urinary bladder cancer	9.56e-05	0.0007	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	9.31e-05	0.000681	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.98e-05	0.000657	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	8.64e-05	0.000632	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RBX1—urinary bladder cancer	8.44e-05	0.000617	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	8.22e-05	0.000602	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	8.19e-05	0.000599	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	8.19e-05	0.000599	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NAT1—urinary bladder cancer	8.19e-05	0.000599	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	8.15e-05	0.000597	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	8.05e-05	0.000589	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	8.01e-05	0.000586	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NQO1—urinary bladder cancer	7.95e-05	0.000581	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TSC1—urinary bladder cancer	7.93e-05	0.000581	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.7e-05	0.000564	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TYMP—urinary bladder cancer	7.68e-05	0.000562	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—JAG1—urinary bladder cancer	7.55e-05	0.000553	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	7.52e-05	0.000551	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	7.49e-05	0.000548	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.38e-05	0.00054	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	7.15e-05	0.000523	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTO2—urinary bladder cancer	7.13e-05	0.000522	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NAT1—urinary bladder cancer	7.13e-05	0.000522	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	7.06e-05	0.000516	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	7.03e-05	0.000514	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NAT2—urinary bladder cancer	6.95e-05	0.000508	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	6.74e-05	0.000493	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NAT1—urinary bladder cancer	6.66e-05	0.000488	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	6.66e-05	0.000488	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTP1—urinary bladder cancer	6.63e-05	0.000485	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.55e-05	0.00048	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	6.52e-05	0.000477	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—RHOA—urinary bladder cancer	6.39e-05	0.000467	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	6.37e-05	0.000466	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	6.21e-05	0.000454	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—TYMS—urinary bladder cancer	6.16e-05	0.000451	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—S100B—urinary bladder cancer	6.12e-05	0.000447	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	6.09e-05	0.000446	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NCOR1—urinary bladder cancer	6.09e-05	0.000446	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTM1—urinary bladder cancer	6.09e-05	0.000446	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	6.06e-05	0.000444	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—RRM2—urinary bladder cancer	6e-05	0.000439	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.98e-05	0.000438	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	5.87e-05	0.00043	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	5.85e-05	0.000428	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GPX1—urinary bladder cancer	5.83e-05	0.000427	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—RHOA—urinary bladder cancer	5.8e-05	0.000424	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ERCC2—urinary bladder cancer	5.73e-05	0.000419	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL8—urinary bladder cancer	5.61e-05	0.00041	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ENO2—urinary bladder cancer	5.55e-05	0.000406	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HPGDS—urinary bladder cancer	5.55e-05	0.000406	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	5.55e-05	0.000406	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.52e-05	0.000404	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NCOR1—urinary bladder cancer	5.5e-05	0.000402	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	5.49e-05	0.000401	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PRSS3—urinary bladder cancer	5.41e-05	0.000396	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTT1—urinary bladder cancer	5.39e-05	0.000394	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—MTHFR—urinary bladder cancer	5.38e-05	0.000394	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—IL2—urinary bladder cancer	5.36e-05	0.000392	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.3e-05	0.000388	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.29e-05	0.000387	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	5.18e-05	0.000379	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	5.12e-05	0.000374	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	5.1e-05	0.000373	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL8—urinary bladder cancer	5.09e-05	0.000372	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	5.05e-05	0.000369	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.98e-05	0.000364	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TYMP—urinary bladder cancer	4.96e-05	0.000363	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.87e-05	0.000356	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL2—urinary bladder cancer	4.86e-05	0.000356	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TERT—urinary bladder cancer	4.85e-05	0.000355	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.76e-05	0.000349	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.73e-05	0.000346	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NAT2—urinary bladder cancer	4.49e-05	0.000328	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NQO1—urinary bladder cancer	4.48e-05	0.000327	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FGFR3—urinary bladder cancer	4.45e-05	0.000325	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARG—urinary bladder cancer	4.36e-05	0.000319	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.34e-05	0.000318	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TYMP—urinary bladder cancer	4.32e-05	0.000316	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ESR1—urinary bladder cancer	4.32e-05	0.000316	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.24e-05	0.00031	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CREBBP—urinary bladder cancer	4.19e-05	0.000307	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.15e-05	0.000303	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.05e-05	0.000296	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TYMP—urinary bladder cancer	4.04e-05	0.000295	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.95e-05	0.000289	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.92e-05	0.000287	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.91e-05	0.000286	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.88e-05	0.000284	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—RRM2—urinary bladder cancer	3.87e-05	0.000283	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.79e-05	0.000277	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CREBBP—urinary bladder cancer	3.79e-05	0.000277	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF1—urinary bladder cancer	3.74e-05	0.000274	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTP1—urinary bladder cancer	3.73e-05	0.000273	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EGFR—urinary bladder cancer	3.72e-05	0.000272	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NAT2—urinary bladder cancer	3.65e-05	0.000267	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.61e-05	0.000264	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ENO2—urinary bladder cancer	3.59e-05	0.000262	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	3.59e-05	0.000262	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.57e-05	0.000261	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—KRAS—urinary bladder cancer	3.51e-05	0.000257	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.48e-05	0.000255	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	3.48e-05	0.000255	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TYMS—urinary bladder cancer	3.47e-05	0.000254	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—urinary bladder cancer	3.43e-05	0.000251	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTM1—urinary bladder cancer	3.43e-05	0.000251	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NCOR1—urinary bladder cancer	3.43e-05	0.000251	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RHOA—urinary bladder cancer	3.43e-05	0.000251	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.43e-05	0.000251	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.37e-05	0.000247	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GPX1—urinary bladder cancer	3.29e-05	0.00024	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ERCC2—urinary bladder cancer	3.23e-05	0.000236	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ERBB2—urinary bladder cancer	3.17e-05	0.000232	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.15e-05	0.000231	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ENO2—urinary bladder cancer	3.12e-05	0.000229	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HPGDS—urinary bladder cancer	3.12e-05	0.000229	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MTHFR—urinary bladder cancer	3.03e-05	0.000222	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.03e-05	0.000222	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL8—urinary bladder cancer	3.01e-05	0.00022	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTEN—urinary bladder cancer	2.99e-05	0.000219	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—HRAS—urinary bladder cancer	2.99e-05	0.000219	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.92e-05	0.000214	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.92e-05	0.000214	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.9e-05	0.000212	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NQO1—urinary bladder cancer	2.89e-05	0.000212	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL2—urinary bladder cancer	2.87e-05	0.00021	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—EP300—urinary bladder cancer	2.86e-05	0.000209	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.84e-05	0.000208	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.83e-05	0.000207	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.8e-05	0.000205	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCND1—urinary bladder cancer	2.8e-05	0.000205	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.79e-05	0.000204	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—urinary bladder cancer	2.72e-05	0.000199	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.71e-05	0.000198	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PTEN—urinary bladder cancer	2.7e-05	0.000198	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EP300—urinary bladder cancer	2.58e-05	0.000189	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.52e-05	0.000184	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SRC—urinary bladder cancer	2.51e-05	0.000183	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—urinary bladder cancer	2.46e-05	0.00018	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.45e-05	0.000179	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	2.41e-05	0.000176	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CREBBP—urinary bladder cancer	2.36e-05	0.000173	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.35e-05	0.000172	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.33e-05	0.000171	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.28e-05	0.000167	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MYC—urinary bladder cancer	2.25e-05	0.000164	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TYMS—urinary bladder cancer	2.24e-05	0.000164	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	2.22e-05	0.000162	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	2.22e-05	0.000162	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EGFR—urinary bladder cancer	2.2e-05	0.000161	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPX1—urinary bladder cancer	2.12e-05	0.000155	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.1e-05	0.000154	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	2.08e-05	0.000152	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KRAS—urinary bladder cancer	2.08e-05	0.000152	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.99e-05	0.000146	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.96e-05	0.000144	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.96e-05	0.000143	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.95e-05	0.000143	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.93e-05	0.000141	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.93e-05	0.000141	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.93e-05	0.000141	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.9e-05	0.000139	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.85e-05	0.000135	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—urinary bladder cancer	1.85e-05	0.000135	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.82e-05	0.000133	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.81e-05	0.000133	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.8e-05	0.000132	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.8e-05	0.000132	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HRAS—urinary bladder cancer	1.76e-05	0.000129	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.73e-05	0.000126	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.71e-05	0.000125	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.7e-05	0.000124	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTEN—urinary bladder cancer	1.69e-05	0.000123	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—EP300—urinary bladder cancer	1.61e-05	0.000118	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.59e-05	0.000117	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—urinary bladder cancer	1.59e-05	0.000116	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	1.53e-05	0.000112	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.38e-05	0.000101	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.33e-05	9.72e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.29e-05	9.46e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.25e-05	9.14e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.24e-05	9.08e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.09e-05	7.97e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.09e-05	7.96e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.04e-05	7.6e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.02e-05	7.44e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTEN—urinary bladder cancer	9.49e-06	6.94e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—EP300—urinary bladder cancer	9.05e-06	6.62e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTEN—urinary bladder cancer	8.87e-06	6.49e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—EP300—urinary bladder cancer	8.46e-06	6.19e-05	CbGpPWpGaD
